Publications by authors named "Balaji Venugopal"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

36

Total Likes

350

Extended Reach

2,768,266

Social Features

167
O
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Tom Ferguson, Stefan N Symeonides, Jaroslav Hajek, Yen-Hwa Chang, Jae-Lyun Lee, Naveed Sarwar

N Engl J Med· April 2024

Videos about Article: user user

2 5 165 1 2 19 1

View All Article and Social Media Activity
I
Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review.
Natalie Charnley, Kate Fife, Daniel Y C Heng, James Larkin, John McGrane, Balaji Venugopal

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Neal D Shore, Murilo de Almeida Luz, Ugo De Giorgi, Martin Gleave, Geoffrey T Gotto, Balaji Venugopal

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Health Associations of Apical Periodontitis: A Systematic Review of Observational Studies.
Balaji Venugopal, Hemamalini Narasimman, Ananthi Mahalingam, R Naren Kishore, Kavitha Jayavel

Cureus· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging.
Stephen J H Dobbin, Kenneth Mangion, Colin Berry, Giles Roditi, Susmita Basak, Balaji Venugopal

Heart· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor-based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma.
Laurence Albiges, Thomas Powles, Anand Sharma, Balaji Venugopal, Jens Bedke

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial.
Thomas Powles, Toni K Choueiri, Laurence Albiges, Katriina Peltola, Guillermo de Velasco, Balaji Venugopal

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?
Stephen J Freedland, Martin Gleave, Ugo De Giorgi, Antti Rannikko, Christopher M Pieczonka, Balaji Venugopal

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients.
Stephen Rankin, Caitlin Fountain, Alastair J Gemmell, Daire Quinn, Alasdair Henderson, Balaji Venugopal

Clin Sci (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.
Talal El Zarif, Karl Semaan, Wanling Xie, Marc Eid, Martin Zarba, Balaji Venugopal

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.
Angela Meade, Elena Frangou, Babak Choodari-Oskooei, James Larkin, Tom Powles, Balaji Venugopal

Contemp Clin Trials Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results.
Paul Nathan, Balaji Venugopal, Jamshed Ali, Jennifer Allison, Mariangela Ceruso

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cell therapy (REGENACIP), a promising treatment option in chronic limb threatening ischemia - a narrative review.
Sanjay Desai, Digvijay Sharma, Rajesh Srinivas, Venugopal Balaji, Vijay Thakore

Stem Cell Res Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Toni K Choueiri, Thomas Powles, Katriina Peltola, Guillermo de Velasco, Mauricio Burotto, Balaji Venugopal

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis.
Benjamin M P Elyan, Michael K Sullivan, James Hedley, Nicole De La Mata, Angela C Webster, Balaji Venugopal

BJC Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma-Systematic Literature Review of Clinical and Real-World Evidence.
Anand Sharma, Amit Bahl, Ricky Frazer, Esha Godhania, Nicholas Halfpenny, Balaji Venugopal

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients using F-FDG positron emission tomography.
Stephen Rankin, Caitlin Fountain, Alastair J Gemmell, Daire Quinn, Alasdair Henderson, Balaji Venugopal

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials.
Stephen Rankin, Benjamin Elyan, Robert Jones, Balaji Venugopal, Patrick B Mark

JACC CardioOncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Stefan Symeonides

Oncologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence.
Marine Gross-Goupil, Lubomir Bodnar, Matthew T Campbell, Agnieszka Michael, Balaji Venugopal

Clin Genitourin Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, Lisa Pickering, Tom Waddell, Balaji Venugopal

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer.
Stephen J Freedland, Martin Gleave, Ugo De Giorgi, Antti Rannikko, Christopher M Pieczonka, Balaji Venugopal

NEJM Evid· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Stephen J Freedland, Murilo de Almeida Luz, Ugo De Giorgi, Martin Gleave, Geoffrey T Gotto, Balaji Venugopal

N Engl J Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resilience of hospital and allied infrastructure during pandemic and post pandemic periods for maternal health care of pregnant women and infants in Tamil Nadu, India - A counterfactual analysis.
Kandaswamy Paramasivan, Ashwin Prakash, Sarthak Gupta, Bhairav Phukan, Pavithra M R, Balaji Venugopal

PLoS One· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Yu-Hsuen Yang, Sonam Ansel, Aafke Meerveld-Eggink, Francesca Jackson-Spence, Kathrine Rallis, Balaji Venugopal

Clin Genitourin Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis